World Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

World Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7,516	Closed	-$405K	–	1472
2017 Q4	$405K	Sell	7,516 -457	-6%	-$25K	0.01%	981
2017 Q3	$455K	Buy	7,973 +112	+1%	+$6.56K	0.02%	922
2017 Q2	$473K	Sell	7,861 -34	-0.4%	-$1.94K	0.02%	883
2017 Q1	$430K	Buy	+7,895	New	+$389K	0.01%	920

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

World Asset Management's BIVV Position: Q1 2018 in Review

World Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 7,516 shares — an estimated $405K sold.

World Asset Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $473K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

World Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
World Asset Management sold 7,516 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $405K.
World Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
World Asset Management's Bioverativ Inc. Common Stock position peaked at $473K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on World Asset Management's 13F filing for Q1 2018, filed 23 Apr 2018.